
Flight Attendants Reveal Biggest Passenger Pet Peeve
But while flight attendants work hard 30,000 feet in the air to keep people safe, many passengers do something detrimental to themselves and others: walking barefoot into the plane lavatory.
Recently, flight attendants on Reddit lamented about this unbelievably common habit. For your own well-being — and other passengers' — flight attendants would like you to stop doing this, please.
'Passengers use the bathrooms all the time on the airplane with either bare feet or with only socks on,' Elizabeth Regan, a flight attendant at a commercial airline, told HuffPost.
This in-flight habit gives flight attendants 'the ick ' because of what could be on the restroom floor. Hilary Clark, inflight services director for California-based private jet company Planet 9 and former commercial flight attendant, told HuffPost that seeing people use the restroom barefoot is 'quite concerning.' 'During our training, we learned that the liquid on the lavatory floor is often more than just water,' she said.
Not to mention the fact that it's just gross and inconsiderate to other passengers. Regan added, 'It is completely unsanitary.'
In general, public restrooms can be hot spots for germs. A 2015 study from TravelMath found that the lavatory flush button on planes had 265 colony-forming units (CFU) per square inch, compared to 172 CFU on home toilet seats. While most of these germs aren't a huge threat to a healthy adult, it's better to reduce your risk of exposure.
'Airplane lavatories are used frequently by many passengers during flights, leading to high-touch surfaces such as door handles, flush buttons, sink faucets, and toilet seats becoming contaminated with various pathogens,' said Dr. Dahlia Philips, an infectious disease physician and medical director for MetroPlusHealth's Partnership in Care Special Needs Plan. 'Walking barefoot exposes your feet to bacteria, viruses and fungi that can enter through cuts or abrasions on your feet.'
As a general rule, Clark said going barefoot into the lavatory is 'unhygienic and should always be avoided.' She suggests people bring a pair of slippers or put on disposable slippers instead of walking around barefoot. (You could also just keep your regular shoes on.)
Philips agreed, adding that you should wear socks into the lavatory at the very least 'to minimize direct contact with the floor.'
Dr. Gonzalo Bearman, chief of the Division of Infectious Diseases at VCU Health, noted that while airplane lavatories 'generally pose no greater threat than the use of public bathrooms, which are also low risk,' there are several precautions you can take to reduce the likelihood of picking up an infection.
'The best approach to cleanliness is proper handwashing and hand hygiene after the use of the airplane bathroom,' he told HuffPost.
'Also, when flushing the toilet, it is best to close the toilet lid prior to flushing the toilet. This minimizes the risk of a toilet plume —the dispersal of microscopic particles as a result of a toilet flush,' he said. These microscopic particles could potentially cause infections like norovirus, so it's best to avoid them if you can.
Philips suggested using toilet seat covers or lining the toilet with paper, avoiding touching your face after using the toilet, using hand sanitizer afterward, and avoiding drinking or rinsing your mouth with lavatory water.
'Lastly, to avoid recontamination, consider using paper towels to turn off the faucet and open the door,' she said.
You should also practice basic flight courtesy by always cleaning up after using the restroom (and making sure to actually flush the toilet!). 'Leaving a mess is inconsiderate to both the flight attendants and other passengers,' Clark said.
Regan suggested using the airport restroom before you board the plane as well. 'The strangest thing I noticed, and is a pet peeve among fellow flight attendants, is that people wait until they get onto the plane to use the restroom,' Regan said. 'It's mind-boggling that you wouldn't use the restroom while you're in the terminal. It's a nice big restroom with plenty of room to move about, and proper water, soap and amenities are at most gates.'
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Business Journals
9 minutes ago
- Business Journals
BJC Health System reaches new deal with insurer Cigna Healthcare
BJC Health System, the St. Louis-based multistate health care provider, has struck a new deal with insurer Cigna Healthcare that keeps its services in-network for patients covered by the insurer.
Yahoo
37 minutes ago
- Yahoo
FDA Clearance Boosts iRhythm Zio Device Innovation and Fuels Growth Potential
iRhythm Technologies, Inc. (NASDAQ:IRTC) is one of the . The FDA clearance for the Zio AT device upgrades signals the potential for further innovation and stock growth. A patient being monitored with a portable ECG device, showing the effectiveness of the company's products. Based in California, iRhythm Technologies, Inc. (NASDAQ:IRTC) is a digital healthcare company focused on transforming cardiac arrhythmia detection through wearable biosensors and cloud-based data analytics. Zio by iRhythm platform, the company's flagship product, makes use of a wearable biosensor patch and cloud-based analytics for monitoring heart rhythms for extended periods, aiding in the diagnosis of cardiac arrhythmias. iRhythm Technologies, Inc. (NASDAQ:IRTC) recently got the FDA 510(k) clearance for design modifications and labeling updates to its Zio AT device – a prescription-only mobile cardiac telemetry (MCT) system used for long-term ECG monitoring of both symptomatic and asymptomatic heart events. The clearance, effective from 2025, allows the device to remain commercially available in the U.S. Following the clearance, the company also launched Zio ECG Recording and Analysis System in Japan in May 2025, with nationwide availability anticipated by July 2025. Following these developments, Robert W. Baird maintained a Buy rating on the stock with a price target of $160. With a 1.17% uptick in its weekly performance, the stock had a closing price of $137.11 as of July 28, 2025. Insider Monkey database reported 31 hedge funds holding stakes in iRhythm Technologies, Inc. (NASDAQ:IRTC), reflecting a modest level of institutional confidence. While we acknowledge the potential of IRTC as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 11 Best Long Term Low Risk Stocks to Invest in and 13 Best Low Risk High Growth Stocks to Buy Disclosure. None.
Yahoo
an hour ago
- Yahoo
CG Oncology, Inc. (CGON) Reports 75.5% Complete Response in Bladder Cancer Trial
We recently compiled a list of CG Oncology, Inc. stands sixth on our list. CG Oncology, Inc. (NASDAQ:CGON) is a late-stage clinical biopharmaceutical company developing bladder-sparing immunotherapies, with a primary focus on cretostimogene grenadenorepvec, a targeted oncolytic virus therapy for bladder cancer. Their lead program targets high-risk, BCG-unresponsive non-muscle invasive bladder cancer (NMIBC), an area with limited options beyond invasive surgery. Recent data from the Phase 3 BOND-003 trial, presented in June 2025, revealed a 75.5% complete response rate, with 42.3% of patients maintaining that response at 24 months. Impressively, 97.3% remained free of progression to muscle-invasive disease, and 91.6% avoided cystectomy. The therapy was also well-tolerated, with no grade 3 or higher treatment-related adverse events reported. Cretostimogene stands out as a potential new standard for NMIBC, offering durable cancer control without surgery and preserving patients' quality of life. Its promising results have sparked interest in combining it with other therapies like pembrolizumab, further expanding its therapeutic potential. A healthcare specialist in the laboratory testing an Oncology-related product. CG Oncology, Inc. (NASDAQ:CGON) continues to expand its clinical footprint with trials targeting both BCG-naïve and previously treated patients. A Biologics License Application (BLA) is expected soon, supported by strong Phase 2 combination data published in Nature Medicine. The business is also offering expanded access programs, broadening patient reach before full regulatory approval. While we acknowledge the potential of GOOGL as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. Sign in to access your portfolio